156 related articles for article (PubMed ID: 12522515)
1. American pain society pain questionnaire and other pain measures in the assessment of osteoarthritis pain: a pooled analysis of three celecoxib pivotal studies.
Moskowitz RW; Sunshine A; Brugger A; Lefkowith JB; Zhao WW; Geis GS
Am J Ther; 2003; 10(1):12-20. PubMed ID: 12522515
[TBL] [Abstract][Full Text] [Related]
2. Onset and durability of pain relief in knee osteoarthritis: Pooled results from two placebo trials of naproxen/esomeprazole combination and celecoxib.
Holt RJ; Fort JG; Grahn AY; Kent JD; Bello AE
Phys Sportsmed; 2015 Jul; 43(3):200-12. PubMed ID: 26313454
[TBL] [Abstract][Full Text] [Related]
3. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial.
Bensen WG; Fiechtner JJ; McMillen JI; Zhao WW; Yu SS; Woods EM; Hubbard RC; Isakson PC; Verburg KM; Geis GS
Mayo Clin Proc; 1999 Nov; 74(11):1095-105. PubMed ID: 10560596
[TBL] [Abstract][Full Text] [Related]
4. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
Daniels S; Robbins J; West CR; Nemeth MA
Clin Ther; 2009 Jun; 31(6):1192-208. PubMed ID: 19695387
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy and safety of celecoxib and naproxen in the treatment of osteoarthritis of the hip.
Kivitz AJ; Moskowitz RW; Woods E; Hubbard RC; Verburg KM; Lefkowith JB; Geis GS
J Int Med Res; 2001; 29(6):467-79. PubMed ID: 11803730
[TBL] [Abstract][Full Text] [Related]
6. Functional status and health-related quality of life of elderly osteoarthritic patients treated with celecoxib.
Lisse J; Espinoza L; Zhao SZ; Dedhiya SD; Osterhaus JT
J Gerontol A Biol Sci Med Sci; 2001 Mar; 56(3):M167-75. PubMed ID: 11253158
[TBL] [Abstract][Full Text] [Related]
7. Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain.
Clemett D; Goa KL
Drugs; 2000 Apr; 59(4):957-80. PubMed ID: 10804043
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of lumiracoxib in the treatment of osteoarthritis of the knee: a 13-week, randomized, double-blind comparison with celecoxib and placebo.
Sheldon E; Beaulieu A; Paster Z; Dutta D; Yu S; Sloan VS
Clin Ther; 2005 Jan; 27(1):64-77. PubMed ID: 15763607
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial.
Geba GP; Weaver AL; Polis AB; Dixon ME; Schnitzer TJ;
JAMA; 2002 Jan; 287(1):64-71. PubMed ID: 11754710
[TBL] [Abstract][Full Text] [Related]
10. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study.
Singh G; Fort JG; Goldstein JL; Levy RA; Hanrahan PS; Bello AE; Andrade-Ortega L; Wallemark C; Agrawal NM; Eisen GM; Stenson WF; Triadafilopoulos G;
Am J Med; 2006 Mar; 119(3):255-66. PubMed ID: 16490472
[TBL] [Abstract][Full Text] [Related]
11. Response to nonsteroidal anti-inflammatory drugs in African Americans with osteoarthritis of the knee.
Essex MN; O'Connell M; Bhadra Brown P
J Int Med Res; 2012; 40(6):2251-66. PubMed ID: 23321182
[TBL] [Abstract][Full Text] [Related]
12. Predictors of response to cyclo-oxygenase-2 inhibitors in osteoarthritis: pooled results from two identical trials comparing etoricoxib, celecoxib, and placebo.
Bingham CO; Smugar SS; Wang H; Peloso PM; Gammaitoni A
Pain Med; 2011 Mar; 12(3):352-61. PubMed ID: 21332932
[TBL] [Abstract][Full Text] [Related]
13. Fixed-dose combination of enteric-coated naproxen and immediate-release esomeprazole has comparable efficacy to celecoxib for knee osteoarthritis: two randomized trials.
Hochberg MC; Fort JG; Svensson O; Hwang C; Sostek M
Curr Med Res Opin; 2011 Jun; 27(6):1243-53. PubMed ID: 21524238
[TBL] [Abstract][Full Text] [Related]
14. Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo.
Bensen WG; Zhao SZ; Burke TA; Zabinski RA; Makuch RW; Maurath CJ; Agrawal NM; Geis GS
J Rheumatol; 2000 Aug; 27(8):1876-83. PubMed ID: 10955327
[TBL] [Abstract][Full Text] [Related]
15. Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a prospective randomized 13-week study versus placebo and celecoxib.
Fleischmann R; Sheldon E; Maldonado-Cocco J; Dutta D; Yu S; Sloan VS
Clin Rheumatol; 2006 Feb; 25(1):42-53. PubMed ID: 16132165
[TBL] [Abstract][Full Text] [Related]
16. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
Sowers JR; White WB; Pitt B; Whelton A; Simon LS; Winer N; Kivitz A; van Ingen H; Brabant T; Fort JG;
Arch Intern Med; 2005 Jan; 165(2):161-8. PubMed ID: 15668361
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of lumiracoxib 100 mg once daily in knee osteoarthritis: a 13-week, randomized, double-blind study vs. placebo and celecoxib.
Lehmann R; Brzosko M; Kopsa P; Nischik R; Kreisse A; Thurston H; Litschig S; Sloan VS
Curr Med Res Opin; 2005 Apr; 21(4):517-26. PubMed ID: 15899100
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib is as efficacious as naproxen in the management of acute shoulder pain.
Bertin P; Béhier JM; Noël E; Leroux JL
J Int Med Res; 2003; 31(2):102-12. PubMed ID: 12760313
[TBL] [Abstract][Full Text] [Related]
19. First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215].
Wittenberg RH; Schell E; Krehan G; Maeumbaed R; Runge H; Schlüter P; Fashola TO; Thurston HJ; Burger KJ; Trechsel U
Arthritis Res Ther; 2006; 8(2):R35. PubMed ID: 16469112
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of nonsteroidal anti-inflammatory drugs in Asian patients with knee osteoarthritis: summary of a randomized, placebo-controlled study.
Essex MN; O'Connell MA; Behar R; Bao W
Int J Rheum Dis; 2016 Mar; 19(3):262-70. PubMed ID: 25990559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]